This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
ORANGEBURG, N.Y., March 6, 2013 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc. (Nasdaq:VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath
® technology, today announced that Cynthia Ansari, President and Chief Executive Officer, will present at 4:00 PM Central Standard Time at the Canaccord Genuity Musculoskeletal Conference in Chicago on Tuesday, March 19th at the Westin Michigan Avenue.
The presentation will also be available via a live audio webcast at the following link:
Following the presentation, a replay will be available through Vision-Sciences' website at
www.visionsciences.com under the "Investor Relations" section and will remain available for thirty days after the actual presentation date.
About Vision-Sciences, Inc.
Vision-Sciences, Inc. designs, develops, manufactures and markets products for flexible endoscopy. Vision-Sciences' unique flexible endoscopic products utilize a streamlined visualization system and proprietary sterile disposable microbial barrier, known as EndoSheath technology, to provide users quick, efficient endoscope turnover while ensuring enhanced patient safety through the use of sterile, single-use technology. Within its medical segment, Vision-Sciences targets five main areas for its fiber and video endoscopes and EndoSheath technology: urology, pulmonology, gastroenterology (GI), ENT (ear, nose and throat) and spine. Information about Vision-Sciences' products is available at
® and The Vision System
® are registered trademarks of Vision-Sciences, Inc.
The Vision-Sciences, Inc. logo is available at
CONTACT: Keith Darragh
VP, Finance and Principal Financial and Accounting Officer
In-Site Communications, Inc.